 |
|
Government cash injection for University spin-out company's stem cell research
January 24, 2005A spin-out company from the University of Nottingham has been awarded around £250,000 of Government funding to develop innovative stem cell therapies that could one day provide new treatments for patients suffering from illnesses including Parkinson's disease and stroke.
RegenTec, a company at the cutting-edge of regenerative medicine that specialises in the development of stem cell and tissue engineering technology, is a partner in two projects that have attracted a total of £3.7 million from the Department of Trade and Industry's Technology Programme.
The first award, made to a five-partner consortium led by the company ReNeuron, will bring together science and industry experts to develop new stem cell products for commercial use in treating neurodegenerative diseases such as stroke, Huntington's disease and Parkinson's disease, as well as other illnesses including diabetes, blindness and cardiac disease.
RegenTec will be working on the development of delivery systems that provide a supportive environment for stem cells. Once administered, the stem cells either encourage the growth of tissue by triggering the body's own repair processes or themselves begin to grow and form new tissue.
The second project, led by the company NovaThera, will aim to develop our understanding of the way in which cells grow and develop into specific cells for different functions. The research, which will initially focus on cells to repair bone, lung and liver tissue, will look at ways in which this growth can be effectively controlled or manipulated.
RegenTec specialises in the development of a range of materials that can be injected to deliver cells directly to the area of the body where they are needed. The materials are designed to solidify upon injection to create templates for tissue repair known as scaffolds. The scaffolds aim to enhance the survival and function of the stem cells and provide a controlled environment that encourages the cells to grow. Research will also be carried out into ways of taking scarce stem cells and growing a larger supply for use in treating a range of patients and diseases.
RegenTec, which is based at BioCity, Nottingham's groundbreaking new healthcare and bioscience innovation centre, was set up four years ago by The University of Nottingham's Professor Kevin Shakesheff.
Welcoming the DTI grant funding, Professor Shakesheff said: "Stem cell technology could revolutionise the treatment of life-threatening or long-term diseases. These awards confirm RegenTec's position as a key partner in advancing regenerative medicine from The University of Nottingham's world-class research labs through to patient treatments.
"I'm delighted that the partnership between the University and RegenTec is again generating biotech jobs at BioCity Nottingham."
Nottingham, University of
RegenTec will be working on the development of delivery systems that provide a supportive environment for stem cells. Once administered, the stem cells either encourage the growth of tissue by triggering the body's own repair processes or themselves begin to grow and form new tissue.
The second project, led by the company NovaThera, will aim to develop our understanding of the way in which cells grow and develop into specific cells for different functions. The research, which will initially focus on cells to repair bone, lung and liver tissue, will look at ways in which this growth can be effectively controlled or manipulated.
RegenTec specialises in the development of a range of materials that can be injected to deliver cells directly to the area of the body where they are needed. The materials are designed to solidify upon injection to create templates for tissue repair known as scaffolds. The scaffolds aim to enhance the survival and function of the stem cells and provide a controlled environment that encourages the cells to grow. Research will also be carried out into ways of taking scarce stem cells and growing a larger supply for use in treating a range of patients and diseases.
RegenTec, which is based at BioCity, Nottingham's groundbreaking new healthcare and bioscience innovation centre, was set up four years ago by The University of Nottingham's Professor Kevin Shakesheff.
Welcoming the DTI grant funding, Professor Shakesheff said: "Stem cell technology could revolutionise the treatment of life-threatening or long-term diseases. These awards confirm RegenTec's position as a key partner in advancing regenerative medicine from The University of Nottingham's world-class research labs through to patient treatments.
"I'm delighted that the partnership between the University and RegenTec is again generating biotech jobs at BioCity Nottingham."
Nottingham, University of
Stem Cells Current Events and Stem Cells News RSSForsyth scientists trigger cancer-like response from embryonic stem cells
Scientists from The Forsyth Institute, working with collaborators at Tufts and Tuebingen Universities, have discovered a new control over embryonic stem cells' behavior.
Yamanaka eliminates viral vector in stem cell reprogramming
Shinya Yamanaka MD, PhD, of Kyoto University and the Gladstone Institute of Cardiovascular Disease (GICD) has taken another step forward in improving the possibilities for the practical application of induced pluripotent stem (iPS) cell technology.
A link between mitochondria and tumor formation in stem cells
Researchers report on a previously unknown relationship between stem cell potency and the metabolic rate of their mitochondria -a cell's energy makers. Stem cells with more active mitochondria also have a greater capacity to differentiate and are more likely to form tumors.
Landmark study unlocks stem cell, DNA secrets to speed therapies
In a groundbreaking study led by an eminent molecular biologist at Florida State University, researchers have discovered that as embryonic stem cells turn into different cell types, there are dramatic corresponding changes to the order in which DNA is replicated and reorganized.
Fat injections can improve breast reconstruction -- jury's out on augmentation
Injecting fat after breast reconstruction to correct implant wrinkling or dimpling may be safe and effective to improve breast shape.
Mayo researchers explore issues related to multiple myeloma treatment
Multiple myeloma (MM) is a cancer of plasma cells that affects approximately 3 in 100,000 people each year. Although there is no cure for this disease, researchers have developed treatments that help relieve pain, control complications, and slow the progress of MM in many patients.
Reversible 3-D cell culture gel invented
Singapore's Institute of Bioengineering and Nanotechnology (IBN), which celebrates its fifth anniversary this year, has invented a unique user-friendly gel that can liquefy on demand, with the potential to revolutionize three-dimensional (3D) cell culture for medical research.
The small cell neuroendocrine carcinoma of the ampulla of vater
Ampullary small cell neuroendocrine carcinoma is extremely rare and has only been documented in few case reports and retrospective study. The patients with ampullary small cell neuroendocrine carcinoma usually presented after the age of 60 years, and a male predilection was observed.
Researchers Find an Essential Gene for Forming Ears of Corn
Cold Spring Harbor Laboratory (CSHL) professor David Jackson, Ph.D., and a team of plant geneticists have identified a gene essential in controlling development of the maize plant, commonly known in the United States as corn.
Pittsburgh researchers identify source of multipotent stem cells with broad regenerative potential
In a promising finding for the field of regenerative medicine, stem cell researchers at Children's Hospital of Pittsburgh of UPMC have identified a source of adult stem cells found on the walls of blood vessels with the unlimited potential to differentiate into human tissues such as bone, cartilage and muscle.
More Stem Cells Current Events and Stem Cells News Articles
 | Essentials of Stem Cell Biology by Robert Lanza, E. Donnall Thomas, James Thomson, Roger Pedersen, John Gearhart, Brigid Hogan, Douglas Melton, Michael West This abridged version of the bestselling reference Handbook of Stem Cells, Two-Volume Set attempts to incorporate all the essential subject matter of the original two-volume edition in a single volume. The material has been reworked in an accessible format suitable for students and general readers interested in following the latest advances in stem cells, including full color presentation... |
 | Stem Cell Now by Christopher Thomas Scott The essential account of the most important scientific advance—and most volatile ethical debate—of our time While many believe stem cell research holds the key to curing a wide range of ailments, others see this research as opening a Pandora’s box that will devalue human life. In Stem Cell Now, Christopher Scott—executive director of Stanford University’s Stem Cells and Society... |
 | The Human Embryonic Stem Cell Debate: Science, Ethics, and Public Policy (Basic Bioethics) CHOICE Outstanding Academic Book for 2002 Human embryonic stem cells can divide indefinitely and have the potential to develop into many types of tissue. Research on these cells is essential to one of the most intriguing medical frontiers, regenerative medicine. It also raises a host of difficult ethical issues and has sparked great public interest and controversy. This book offers a... |
 | Sex, Science, and Stem Cells by Diana DeGette In August 2001, President George W. Bush announced with fanfare that federal funds would be made available to scientists conducting research on human embryonic stem cell lines—with restrictions. Reading his words, not his lips, was Congresswoman Diana DeGette of Colorado’s First Congressional District, and what she read was this: a ban. “As a practical matter,” scientists could no longer... |
 | The Stem Cell Controversy: Debating the Issues (Contemporary Issue Series) Stem cell research is headline news. Researchers are eager to move forward, state governments and private foundations are rushing to support it, and the sick and afflicted are desperate for its benefits. Yet powerful forces in our society—led by President George W. Bush—find it morally troubling and they are doing all in their powers to restrict its development beyond a very limited scale. ... |
 | Basic Questions on Genetics, Stem Cell Research and Cloning: Are These Technologies Okay to Use? (Biobasics Series) (BioBasics Series) by Linda K. Bevington, Ray G. Bohlin, Gary P. Stewart, John F. Kilner Cutting-edge medical ethics issues are addressed by nationally recognized experts. The BioBasics Series confronts the maze of challenging questions with biblical responses and uncompromising respect for all human... |
 | Fundamentals of the Stem Cell Debate: The Scientific, Religious, Ethical, and Political Issues Few recent advances in science have generated as much excitement and controversy as human embryonic stem cells. The potential of these cells to replace diseased or damaged cells in virtually every tissue of the body heralds the advent of an extraordinary new field of medicine. Controversy arises, however, because current techniques required to harvest stem cells involve the destruction of the... |
 | The Stem Cell Divide: The Facts, the Fiction, and the Fear Driving the Greatest Scientific, Political, and Religious Debate of Our Time by Michael Bellomo There has been much recent debate about the merits, dangers, and nature of stem cell research. Some see in it the answer to every debilitating disease known to man, while others see it as a step away from human cloning. While the battle has raged, research is moving ahead, and California has already passed a measure that will give $3 billion in support to stem cell research. But as politics,... |
 | Mesenchymal Stem Cells: Methods and Protocols (Methods in Molecular Biology) For over forty years, mesenchymal stem cells (MSCs) have been scrutinized and studied, garnering much attention due to their broad therapeutic efficacy. In Mesenchymal Stem Cells: Methods and Protocols, leaders in the field were assembled to contribute detailed methodologies for the isolation and characterization of human and rodent MSCs. Recently, these vital cells have shown therapeutic... |
 | Human Stem Cell Manual: A Laboratory Guide Stem cells are self-replicating and undifferentiated, meaning their function is not yet cell, tissue, or organ-specific. Due to the unique nature of these cells, research into their biology and function holds great promise for therapeutic applications through replacement or repair of diseased and damaged cells. This reader-friendly manual provides a practical "hands on" guide to the culture of... |
| © 2008 BrightSurf.com |